Followers | 211 |
Posts | 107980 |
Boards Moderated | 2 |
Alias Born | 09/26/2005 |
Monday, October 12, 2009 8:09:45 AM
Onyx will acquire Proteolix and its blood cancer drug candidate in deal worth up to $851M
On 8:02 am EDT, Monday October 12, 2009
Buzz up! 0 Print.Companies:Onyx Pharmaceuticals Inc.
NEW YORK (AP) -- Onyx Pharmaceuticals Inc. said Monday it will buy cancer drug developer Proteolix Inc. in a deal that could be worth as much as $851 million.
Related Quotes
Symbol Price Change
ONXX 26.90 0.00
{"s" : "onxx","k" : "c10,l10,p20,t10","o" : "","j" : ""} Onyx will pay $276 million upfront for the privately held South San Francisco company, and in the process it gains Proteolix's cancer drug candidate carfilzomib, which is being tested as a treatment for multiple myeloma, non-Hodgkin lymphoma, and solid tumors. Its drugs are designed to trigger cancer cell death with minimal damage to the rest of the patient's body.
Onyx, of South San Francisco, will pay another $40 million next year if carfilzomib reaches a development milestone, and will pay another $535 million if carfilzomib is approved in the U.S. and Europe. That includes a $170 million payment if the Food and Drug Administration decides to conduct a fast review of the drug.
The deal is expected to close in the fourth quarter, Onyx said.
Proteolix is conducting mid-stage clinical trials of carfilzomib as a standalone treatment for multiple myeloma, which is a cancer of the blood, and as a treatment for solid tumors. It is also running early-stage tests of carfilzomib as part of a combination therapy in addition to the lymphoma study.
The company is also testing an orally-dosed cancer drug, and is doing research on immunoselective compounds.
In premarket trading on Monday, Onyx shares rose 43 cents to $27.33.
(This version CORRECTS spelling of Onyx.)
Join our E-Mailing List... http://investorshub.advfn.com/boards/chairmail_sub.asp?board_id=6908
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM